DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...
Icon reported over $2 billion in revenue in the third quarter, up 1.3% from the prior-year period. Adjusted EBITDA was nearly $397 million in the quarter, or 19.4% of revenue. Management raised its ...
Icon delivered gross business wins of $2.97 billion in the second quarter, representing a 10% increase compared with the first quarter of 2025. Investors reacted positively and sent the stock up 14%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results